DOCS DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

Rosen Law Firm has issued deadline notices for securities class action lawsuits against Doximity, Inc. and Ardelyx, Inc., with a November 16, 2026 lead plaintiff deadline. The firm is also announcing a newly filed lawsuit against NVIDIA Corporation. Investors who purchased shares during specified class periods may be eligible for compensation.

11/09/2026, 9:39 PM • GlobeNewswire

ARDX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDX

Rosen Law Firm has filed securities class action lawsuits against Ardelyx, Doximity, and NVIDIA. The primary case detailed involves Ardelyx, where investors who purchased stock between January 13, 2025 and August 6, 2026 may be entitled to compensation. The lawsuit alleges the company made materially false statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing reimbursement barriers and prior authorization issues that hindered patient access. The lead plaintiff deadline is November 16, 2026.

11/09/2026, 9:14 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardelyx, Inc. alleging that the company made false and misleading statements regarding its commercial performance. The complaint claims Ardelyx failed to disclose increasing payer-related access barriers, stringent prior authorization requirements, and negative impacts on growth prospects for its drugs XPHOZAH and IBSRELA during the period from January 13, 2025 to August 6, 2026.

11/09/2026, 11:00 AM • GlobeNewswire

ARDX DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDX

Rosen Law Firm is alerting investors in Ardelyx, Inc. (NASDAQ: ARDX) about a November 16, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Ardelyx provided false and misleading statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing material facts about payer access barriers, prior authorization requirements, and step edit requirements that hindered patient access and new-patient starts.

11/06/2026, 5:41 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardelyx, Inc. (NASDAQ: ARDX) alleging that the company made false and misleading statements regarding its commercial performance. The complaint claims Ardelyx failed to disclose increasing payer-related access barriers, stringent prior authorization requirements, and negative impacts on growth prospects for its drugs XPHOZAH and IBSRELA. Investors who purchased Ardelyx securities between January 13, 2025 and August 6, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.

11/05/2026, 11:00 AM • GlobeNewswire

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

A securities class action lawsuit has been filed against Ardelyx, Inc. for allegedly providing false and misleading statements to investors regarding the commercial performance and growth prospects of its drugs XPHOZAH and IBSRELA. The lawsuit claims defendants concealed material facts about payer-related access barriers, prior authorization requirements, and step edit requirements that hindered patient access. Investors who purchased stock between January 13, 2025 and August 6, 2026 may be eligible for compensation. The lead plaintiff deadline is November 16, 2026.

11/03/2026, 7:58 PM • GlobeNewswire

HONA FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Honeywell Aerospace Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HONA

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Honeywell Aerospace Inc. (HONA), where the firm alleges the company made false statements regarding supplier concentration risks, supply constraints, and undisclosed government contract investigations. Similar class actions have been filed against Gildan Activewear Inc. (GIL) and Ardelyx, Inc. (ARDX). Investors have until November 23, 2026 to become lead plaintiffs.

11/03/2026, 7:53 PM • GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Triller Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILLR

Rosen Law Firm is reminding investors in Triller Group Inc., Gildan Activewear Inc., and Ardelyx Inc. of upcoming deadlines to join securities class action lawsuits. The lawsuits allege that these companies made materially false and misleading statements regarding financial controls, business operations, and regulatory compliance. Investors who purchased securities during specified class periods may be eligible for compensation.

11/03/2026, 7:35 PM • GlobeNewswire

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages O-I Glass, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OI

Rosen Law Firm has filed securities class action lawsuits against O-I Glass, Gildan Activewear, and Ardelyx on behalf of investors who purchased shares during specified periods. The lawsuits allege that defendants made materially false and misleading statements regarding financial outlooks and business performance while concealing adverse facts. Investors who purchased shares during the class periods may be entitled to compensation.

11/03/2026, 7:08 PM • GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP

Rosen Law Firm is reminding investors in Millrose Properties, Gildan Activewear, and Ardelyx of upcoming deadlines to join securities class action lawsuits. The firm alleges that Millrose Properties failed to disclose material information about its business operations, including undisclosed lease agreements and property purchases from Lennar Corporation at a loss. Similar class actions have been filed against the other companies, with lead plaintiff deadlines approaching in December 2026.

11/03/2026, 7:03 PM • GlobeNewswire

Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Ardelyx, Inc. alleging that the company made false and misleading statements regarding its commercial performance. The complaint claims Ardelyx failed to disclose increasing payer-related access barriers, stringent prior authorization requirements, and negative impacts on growth prospects for its drugs XPHOZAH and IBSRELA. Investors who purchased securities between January 13, 2025 and August 6, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 16, 2026.

11/02/2026, 11:00 AM • GlobeNewswire

HONA DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Honeywell Aerospace Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HONA

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. Honeywell Aerospace faces allegations of false statements regarding supplier dependencies and cybersecurity compliance issues. Anavex Life Sciences and Ardelyx, Inc. also have pending class actions with November 2026 deadlines for lead plaintiff claims.

10/31/2026, 8:28 PM • GlobeNewswire

ANAVEX DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL

Rosen Law Firm is reminding investors in Anavex Life Sciences, Ardelyx, and Alphabet Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The Anavex case alleges false statements regarding internal controls and regulatory challenges related to former CEO misconduct. Investors with losses exceeding $100K are encouraged to secure counsel before the November 30, 2026 deadline.

10/31/2026, 1:22 PM • GlobeNewswire

ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

Rosen Law Firm is notifying Ardelyx, Inc. investors of a securities class action lawsuit with a November 16, 2026 lead plaintiff deadline. The lawsuit alleges that Ardelyx made materially false and misleading statements regarding commercial performance and growth prospects for its drugs XPHOZAH and IBSRELA, while concealing information about payer access barriers, prior authorization requirements, and step edit requirements that hindered patient access and new-patient starts.

10/31/2026, 11:35 AM • GlobeNewswire

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX

Rosen Law Firm is notifying investors who purchased Ardelyx common stock between January 13, 2025 and August 6, 2026 of an important November 16, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Ardelyx provided false and misleading statements regarding commercial performance and growth prospects for its products XPHOZAH and IBSRELA, while concealing material facts about payer-related access barriers, prior authorization requirements, and step edit requirements that hindered patient access.

10/25/2026, 9:43 PM • GlobeNewswire